Grupo Supervielle S.A. (BCBA:SUPV)

Theseus Pharmaceuticals Statistics

Total Valuation

BCBA:SUPV has a market cap or net worth of ARS 1.19 trillion.

Market Cap	1.19T
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	Apr 29, 2025

Share Statistics

BCBA:SUPV has 437.73 million shares outstanding. The number of shares has decreased by -0.95% in one year.

Current Share Class	375.99M
Shares Outstanding	437.73M
Shares Change (YoY)	-0.95%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	25.67%
Owned by Institutions (%)	21.91%
Float	275.88M

Valuation Ratios

The trailing PE ratio is 19.70 and the forward PE ratio is 9.98.

PE Ratio	19.70
Forward PE	9.98
PS Ratio	1.50
PB Ratio	1.32
P/TBV Ratio	1.65
P/FCF Ratio	36.10
P/OCF Ratio	13.48
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	10.76
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 8.39%.

Return on Equity (ROE)	8.39%
Return on Assets (ROA)	1.54%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	231.64M
Profits Per Employee	17.62M
Employee Count	3,663
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BCBA:SUPV has paid 11.60 billion in taxes.

Income Tax	11.60B
Effective Tax Rate	15.91%

Stock Price Statistics

The stock price has increased by +69.35% in the last 52 weeks. The beta is 0.91, so BCBA:SUPV's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	+69.35%
50-Day Moving Average	2,811.10
200-Day Moving Average	3,099.65
Relative Strength Index (RSI)	53.25
Average Volume (20 Days)	919,279

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BCBA:SUPV had revenue of ARS 797.30 billion and earned 60.66 billion in profits. Earnings per share was 138.34.

Revenue	797.30B
Gross Profit	797.30B
Operating Income	162.58B
Pretax Income	72.89B
Net Income	60.66B
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	138.34

Balance Sheet

The company has 332.56 billion in cash and 355.53 billion in debt, giving a net cash position of -22.97 billion or -52.47 per share.

Cash & Cash Equivalents	332.56B
Total Debt	355.53B
Net Cash	-22.97B
Net Cash Per Share	-52.47
Equity (Book Value)	901.07B
Book Value Per Share	2,054.41
Working Capital	-3,230.39B

Cash Flow

In the last 12 months, operating cash flow was 88.46 billion and capital expenditures -55.41 billion, giving a free cash flow of 33.04 billion.

Operating Cash Flow	88.46B
Capital Expenditures	-55.41B
Free Cash Flow	33.04B
FCF Per Share	75.48

Margins

Gross Margin	n/a
Operating Margin	20.39%
Pretax Margin	9.14%
Profit Margin	7.61%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	4.14%

Dividends & Yields

This stock pays an annual dividend of 62.00, which amounts to a dividend yield of 2.19%.

Dividend Per Share	62.00
Dividend Yield	2.19%
Dividend Growth (YoY)	40.78%
Years of Dividend Growth	1
Payout Ratio	46.10%
Buyback Yield	0.95%
Shareholder Yield	3.15%
Earnings Yield	5.09%
FCF Yield	2.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4